Express News | Outlook Therapeutics Inc - Restructuring Payments Expected to Be Complete by Q3 2025

ReutersDec 16 16:13 ET

Outlook Therapeutics to Cut 23% Workforce to Lower Costs

MT NewswiresDec 13 17:00 ET

Outlook Therapeutics Streamlines Operations, Cuts Workforce By 23% For $1.4M Annual Savings, Aims To Launch LYTENAVA In EU/UK, Prepares BLA Resubmission In Q1 2025 Despite NORSE EIGHT Trial Not Meeting Endpoint; LYTENAVA Receives NICE Recommendation,...

BenzingaDec 13 16:31 ET

Express News | Outlook Therapeutics Inc - to Resubmit Bla Application for Ons-5010 in Q1 2025

ReutersDec 13 16:30 ET

Express News | Outlook Therapeutics Inc - Implements Initiatives to Streamline Organization and Reduce Expenses

ReutersDec 13 16:30 ET

Outlook Therapeutics Streamlines Operations

GlobeNewswireDec 13 16:30 ET